Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved for this use. Both drugs are approved for ...

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.

People who’ve been using more affordable copycat versions of Ozempic or Wegovy to lose weight will no longer have that option. “They are generally much more accessible — you can get them ...

Americans spent an estimated $71.7 billion on GLP-1 drugs including Ozempic ... Wegovy in 2023, a 500 percent increase from their spending on such drugs five years earlier, according to a research ...

FDA Alerts The ruling reinforces the FDA’s position that Novo Nordisk’s Ozempic and Wegovy supplies meet or exceed national demand. Following the court’s decision, the FDA is now authorized ...

A federal judge in Texas late Thursday rejected a bid by compounding pharmacies to keep making copies of Ozempic and Wegovy while a ... seizures and warning letters to pharmacies.